New Website
Our new website combines information and patient stories into a one stop-shop for people living with GBM and their loved ones.  For those recently diagnosed, we cover the standard of care plus essential questions to ask your doctor. The site features clear information about the science behind GBM — including genomic testing, clinical trials, novel treatments — and more. 

Be #HeadStrong in May, Brain Tumor Awareness Month
Like our founder Jessica Morris's son Felix, take a selfie or velfie (short video) and share during May. To do so, make a fist, flex your bicep, and point to your head for being HeadStrong. Share on your social with #HeadStrong #OurBrainBank #GoGrayInMay #BrainTumorAwarenessMonth Please tag us @OurBrainBank.

OurBrainBank is asking for donations as small as a dollar and as large as imaginable to help fight brain cancer. Thank you for being HeadStrong!

Join us in Sacramento for our next event: May 27
Our first fundraising event in Pasadena was a huge success, raising much-needed funds and awareness. Please join us for our next one in Sacramento on May 27. We're actively seeking local involvement, so please get in touch if you live in that region. If you're on Facebook, please share the event page. 

Ask the FDA to accelerate the clinical trial process
The Food and Drug Administration is taking public comments about a new draft guidance: Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products.

This is a complex issue, but in a nutshell, trial protocol could be improved. People with GBM have no time to waste and need the treatment being tested NOW, not a placebo. Learn more and let your voice be heard. Our friends at End Brain Cancer have a comprehensive explanation. Deadline is May 2, 2023.

OurBrainBank board member Gail Fosler (1947-2023)
We are saddened to announce that our board member Gail Fosler has died. She was dedicated to making a difference and will be greatly missed. Read about her interesting life and career in her Washington Post obituary. 
 

Good results from a clinical trial
Novocure, the maker of the Optune device for GBM (Tumor Treating Fields) announced good results in lung cancer trial.